The company manufactures and sells the renown NanoOne series of laser-powered 2PP 3D-printing systems that are able to build structures across twelve orders of magnitude at an unprecedented speed. The company’s expansion follows a year of strong business growth, seeing the company’s sales triple and market interest rising strongly.

Parallel with establishing a global sales division, staff and floor space at the Viennese headquarter have been expanded significantly. Now the company also follows an increasing interest from the US by appointing Erika Bechtold to its leadership team as the incoming VP for the US operations in Boston, Massachusetts.

“Demand for our NanoOne printer-range has grown steadily in the last years and 2021 saw another tripling of sold units”, comments Bernhard Küenburg, CEO of UpNano. “By extending the range of our printers, offering retrofit modular solutions and consistently innovating new printing resins, we continue to strive to meet expectations from industry and academia alike.”

Erika Bechtold, PhD, is currently the director of technology commercialization at Harvard’s office for technology development, supporting the Wyss Institute for Biologically Inspired Engineering, at Harvard. She brings with her over ten years of business development and commercial strategy experience from both academia an industry. “I am so impressed with the NanoOne systems that the team has built”, comments Bechtold. “UpNano is at a pivotal time of growth, and I’m excited to be joining the team to help promote this commercial-stage system in the US. It’s such a great opportunity at a time of noticeable growth in the 2PP 3D-printing markets.”

In addition to leading UpNano’s US operations, Bechtold will also be involved in supporting ImageBiopsy Lab. With offices in Austria and the US, ImageBiopsy Lab develops and deploys medical-AI software in the field of musculoskeletal imaging intelligence, enabling physicians and healthcare providers to turn large sets of unstructured data into diagnostic evidence. Both UpNano and ImageBiopsy Lab are supported, in part, by the same investment group.